ArticleNPJ Parkinson's disease2025
Cognitive function correlates with gastric alpha-synuclein seeding activity in early Parkinson's disease.
Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The gut neuroepithelial unit as a neurodegeneration-relevant interface in the gut-brain axis.Translational neurodegeneration · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Alpha-synuclein (AS) accumulation is more frequently detected in the stomach than in the colon of patients with Parkinson's disease (PD), suggesting its potential as a pathologic biomarker. This study is to evaluate the diagnostic performance of real-time quaking-induced conversion assay on stomach biopsies for early PD and its association with clinical characteristics. Stomach biopsy tissues were prospectively collected from 22 patients with early-stage PD and 17 controls. Pathological AS-seeding activity was assessed, and correlations between kinematic parameters and clinical features were analyzed with age adjustment. Pathological AS-seeding activity was detected in 45.5% of patients with PD and in none of the controls. The Montreal Cognitive Assessment score was correlated with the lag time of positive replicates (Spearman's ρ = 0.742; p = 0.022), after age adjustment. The AS seed amplification assay using the stomach tissue may serve as a biomarker reflecting disease pathophysiology of the gut-brain axis in PD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.